Void · Coders disagree
Rules 1.1.0 · as of 14 Sep 2026
Rick Doblin · Said 8 Apr 2022 · doblin-0170
Quote
“In MAPS' 36th year, we'll learn if our second Phase 3 study of MDMA-assisted therapy for PTSD was successful. If so, FDA approval will likely take place in MAPS' 37th year, and MAPS will also likely outlive me, which is a legacy to be proud of.”
MAPS 36th-anniversary post quoting Doblin in quotation marks. Conditional call that FDA approval follows in MAPS' 37th year (the year after April 2022).